Interleukin (IL)-10, an anti-inflammatory cytokine, is expressed in the brain and can inhibit microglial activation. Herein, we utilized lipopolysaccharide (LPS)-induced inflammatory Parkinson's disease (PD) cell model to determine whether microglia and astrocytes are necessary targets for IL-10 neuroprotection. Primary ventral mesencephalic (VM) cultures with different composition of neurons, microglia and astrocytes were prepared. The cells were exposed to IL-10 (15, 50 or 150 ng/mL) 1 h prior to LPS (50 ng/mL) treatment. LPS induced dopaminergic and non-dopaminergic neuronal loss in VM cultures, VM neuron-enriched cultures, and neuron-microglia co-cultures, but not in neuron-astrocyte co-cultures. IL-10 reduced LPS-induced neuronal loss particularly in single VM neuron cultures. Pro-inflammatory mediators (TNF-α, IL-1β, inducible nitric oxide synthase and cyclooxygenase-2) were upregulated in both neuron-microglia and neuron-astrocyte co-cultures by LPS. In contrast, neurotrophic factors (brain-derived neurotrophic factor, insulin-like growth factor-1 or glial cell-derived neurotrophic factor) were downregulated in neuron-microglia co-cultures, but upregulated in neuron-astrocyte co-cultures by LPS. IL-10 reduced both the increase in production of the pro-inflammatory mediators and the decrease in production of the neurotrophic factors induced by LPS. These results suggest that astrocytes can balance LPS neurotoxicity by releasing more neurotrophic factors and that IL-10 exerts neuroprotective property by an extensive action including direct on neurons and indirect via inhibiting microglial activation.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1mKocGr
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
►
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
▼
2015
(1500)
-
▼
Δεκεμβρίου
(1450)
-
▼
Δεκ 28
(50)
- SARC009: Phase 2 study of dasatinib in patients wi...
- Identification of patient subgroups with markedly ...
- Oncolytic reovirus in combination with chemotherap...
- Disparities in the use of screening magnetic reson...
- Polymorphisms of CASR gene increase the risk of pr...
- Efficacy and safety of growth hormone treatment in...
- Absence of the BRAF V600E mutation in pheochromocy...
- Immunoexpression of Ki-67, MCM2, and MCM3 in Amelo...
- Thief steals equipment from Okla. fire dept. ambul...
- Thief steals equipment from Okla. fire dept. ambul...
- Time to contrast enema and ileostomy closure rates...
- Child Asthma Rates Leveling Off, Except Among Poor...
- Health Tip: Start a Group Training Session
- Health Tip: Four Simple Steps for Healthier Eating
- Toxins, Vol. 8, Pages 5: Development of an Enzyme-...
- Influence of the Alcohol Present in a Phytotherapi...
- Behavior of melanocytes and keratinocytes in retic...
- Remodelling of elastic fibres in striae gravidarum
- News and Notices
- Fragrance contact allergy in the population
- Burden of disease scoring in epidermolysis bullosa
- The clinical relevance of dermoscopic naevus patterns
- Growth and hormonal profiling in children with con...
- Navigating uncertainty: a valuable cost-effectiven...
- Can we trust questions about self-reported and car...
- Does systemic antipsoriatic therapy affect the car...
- Occupational contact urticaria: a diagnosis not to...
- British Society for Paediatric Dermatology Annual ...
- BJD in translation
- Chilblain lesions associated with inherited autoim...
- Conflicts of interest in dermatology: a medical st...
- Editor's Choice
- Plain language summaries
- Next-generation antipsoriatic drugs: small molecul...
- Paraneoplastic pemphigus: an entity still in searc...
- Treatment regimens in vulval lichen sclerosus
- A Case of Tinea Incognito
- Wnt5a-Ror2 signaling in mesenchymal stem cells pro...
- FOXA1 expression affects to the proliferation acti...
- New Roles for Lysine Demethylase KDM4A
- Maternal dietary fat intake during pregnancy is as...
- Spatial variation in osteon population density at ...
- Clinical significance of accounting for tissue het...
- The Best Medical Technologies of 2015
- Timing of routine infant vaccinations and risk of ...
- IJMS, Vol. 17, Pages 37: The Role of bFGF in the E...
- IJMS, Vol. 17, Pages 33: Targeted Radionuclide The...
- IJMS, Vol. 17, Pages 25: Interleukin-10 Protection...
- DAMS Participates in IMA-NATCON
- Echinocandin to fluconazole step-down therapy in c...
-
▼
Δεκ 28
(50)
-
▼
Δεκεμβρίου
(1450)
Ετικέτες
Δευτέρα 28 Δεκεμβρίου 2015
IJMS, Vol. 17, Pages 25: Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου